Related Experiment Video
Updated: Jun 20, 2025

The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and
Dandan Wu1, Stan F J van de Graaf1
1Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Gastroenterology, Endocrinology and Metabolism (AGEM), Amsterdam University Medical Centers, the Netherlands.
Abstract:
The normal liver has an extraordinary capacity of regeneration. However, this capacity is significantly impaired in steatotic livers. Emerging evidence indicates that metabolic dysfunction associated steatotic liver disease (MASLD) and liver regeneration share several key mechanisms. Some classical liver regeneration pathways, such as HGF/c-Met, EGFR, Wnt/β-catenin and Hippo/YAP-TAZ are affected in MASLD. Some recently established therapeutic targets for MASH such as the Thyroid Hormone (TH) receptors, Glucagon-like protein 1 (GLP1), Farnesoid X receptor (FXR), Peroxisome Proliferator-Activated Receptors (PPARs) as well as Fibroblast Growth Factor 21 (FGF21) are also reported to affect hepatocyte proliferation. With this review we aim to provide insight into common molecular pathways, that may ultimately enable therapeutic strategies that synergistically ameliorate steatohepatitis and improve the regenerating capacity of steatotic livers. With the recent rise of prolonged ex-vivo normothermic liver perfusion prior to organ transplantation such treatment is no longer restricted to patients undergoing major liver resection or transplantation, but may eventually include perfused (steatotic) donor livers or even liver segments, opening hitherto unexplored therapeutic avenues.
Insights
Metabolic dysfunction associated steatotic liver disease impairs liver regeneration by affecting key pathways. Targeting these shared mechanisms may improve both steatohepatitis and liver repair capacity.
Area of Science:
- Hepatology
- Molecular Biology
- Regenerative Medicine
Background:
- Normal liver regeneration is robust but impaired in steatotic livers.
- Metabolic dysfunction associated steatotic liver disease (MASLD) shares mechanisms with liver regeneration.
- Key regeneration pathways (HGF/c-Met, EGFR, Wnt/β-catenin, Hippo/YAP-TAZ) are altered in MASLD.
Purpose of the Study:
- To review common molecular pathways linking MASLD and liver regeneration.
- To identify therapeutic strategies for ameliorating steatohepatitis and enhancing regeneration in steatotic livers.
- To explore novel applications of ex-vivo liver perfusion for therapeutic interventions.
Main Methods:
- Literature review focusing on molecular pathways in MASLD and liver regeneration.
- Analysis of therapeutic targets for MASH (Metabolic dysfunction-associated steatohepatitis) and their role in hepatocyte proliferation.
- Discussion of emerging techniques like ex-vivo normothermic liver perfusion.
Main Results:
- MASLD affects critical liver regeneration pathways.
- Therapeutic targets for MASH, including Thyroid Hormone receptors, GLP1, FXR, PPARs, and FGF21, also influence hepatocyte proliferation.
- Ex-vivo liver perfusion presents new therapeutic possibilities for steatotic livers.
Conclusions:
- Understanding shared molecular pathways is crucial for developing synergistic treatments for MASLD and impaired regeneration.
- Targeting these pathways could improve outcomes for patients with steatotic liver disease.
- Advanced perfusion techniques may enable novel therapeutic strategies for steatotic donor livers or segments.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Tissue Renewal without Stem Cells
However, failure of such a system...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

